SMARCE1 Gene Meningioma Familial Susceptibility NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Meningioma Risk
The SMARCE1 Gene Meningioma Familial Susceptibility NGS Genetic DNA Test represents a breakthrough in preventive oncology, offering individuals with family history of brain tumors the opportunity to understand their genetic predisposition to meningioma development. This advanced genetic screening utilizes next-generation sequencing technology to provide comprehensive analysis of the SMARCE1 gene, which plays a critical role in tumor suppression and cellular regulation.
What This Test Measures and Detects
This sophisticated genetic test specifically targets and analyzes the SMARCE1 gene, which encodes a protein component of the SWI/SNF chromatin remodeling complex. The test detects:
- Pathogenic variants and mutations in the SMARCE1 gene
- Inherited genetic alterations associated with familial meningioma susceptibility
- Specific nucleotide changes that disrupt normal tumor suppressor function
- Genetic markers indicating increased risk for multiple meningioma development
- Variants that may be passed to future generations
Who Should Consider This Genetic Test
This test is particularly recommended for individuals who meet any of the following criteria:
- Personal history of multiple meningiomas or early-onset meningioma
- Family members diagnosed with meningioma, especially multiple cases
- Individuals with first-degree relatives who developed brain tumors
- Patients with family history spanning multiple generations
- Those experiencing unexplained neurological symptoms with family cancer history
- Individuals planning family who want to understand inherited cancer risks
Clinical Benefits of SMARCE1 Genetic Testing
Undergoing SMARCE1 genetic testing provides numerous significant advantages:
- Early Risk Assessment: Identify genetic predisposition before symptom development
- Personalized Surveillance: Implement targeted monitoring protocols for at-risk individuals
- Family Planning Guidance: Make informed decisions about genetic inheritance risks
- Proactive Management: Develop preventive strategies and early intervention plans
- Reduced Anxiety: Clarify uncertainty about inherited cancer risks
- Comprehensive Care: Coordinate with healthcare providers for optimal management
Understanding Your Test Results
Your genetic test results will fall into one of several categories, each with specific implications:
- Positive Result: Indicates presence of a pathogenic SMARCE1 variant, confirming increased meningioma risk and necessitating regular neurological monitoring
- Negative Result: No detected pathogenic variants, suggesting standard population risk levels for meningioma development
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing research and periodic re-evaluation
- No Mutation Detected: Current testing technology did not identify known pathogenic variants in the SMARCE1 gene
All results should be discussed with a qualified genetic counselor or oncologist to develop appropriate follow-up and management strategies.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Test Name | SMARCE1 Gene Meningioma Familial Susceptibility NGS Genetic DNA Test |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
We have established testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many other cities. Our network ensures accessible genetic testing services for patients throughout the country.
Take Control of Your Genetic Health Today
Don’t let uncertainty about hereditary cancer risks affect your peace of mind. Our SMARCE1 genetic testing provides clarity and empowers you with knowledge to make informed healthcare decisions. With our discounted pricing at $500 USD and comprehensive genetic counseling support, you can take proactive steps toward understanding your meningioma risk profile.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.
Early detection through genetic testing can make a significant difference in managing hereditary cancer risks. Take the first step toward personalized cancer prevention by scheduling your SMARCE1 Gene Meningioma Familial Susceptibility NGS Genetic DNA Test today.
